Souders Financial Advisors

Position in GILD — Gilead Sciences, Inc.

CIK 1811240 CINCINNATI, OH

Position in GILD

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$407,193

-$145,130 QoQ

Shares Held

3,223

-18.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#1,484

of 2,266 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Souders Financial Advisors holds $13,208,144 across 10 Drug Manufacturers - General names. GILD ranks #6 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	4,235	$5,079,586
2	ABBV	AbbVie Inc.	8,246	$2,075,023
3	AMGN	Amgen Inc	5,104	$1,848,260
4	MRK	Merck & Co., Inc.	12,395	$1,592,757
5	JNJ	Johnson & Johnson	3,322	$843,688
6	GILD	Gilead Sciences, Inc. This page	3,223	$407,193
7	BMY	Bristol Myers Squibb Co	6,899	$397,520
8	AZN	Astrazeneca PLC	1,928	$365,587

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$407,193	3,223	-18.7%	Shares	Sole	2026-08-05
2026-03-31	$552,323	3,963	+22.0%	Shares	Sole	2026-05-04
2025-12-31	$398,782	3,249	+9.0%	Shares	Sole	2026-02-02
2025-09-30	$330,780	2,980	-14.5%	Shares	Sole	2025-11-04
2025-06-30	$386,271	3,484	+28.4%	Shares	Sole	2025-08-06
2025-03-31	$303,991	2,713	-93.1%	Shares	Sole	2025-05-05
2021-12-31	$2,842,754	39,151	+2.3%	Shares	Sole	2022-02-04
2021-09-30	$2,672,181	38,256	+1.5%	Shares	Sole	2021-11-03
2021-06-30	$2,595,264	37,689	+1.5%	Shares	Sole	2021-08-09
2021-03-31	$2,399,841	37,132	-11.5%	Shares	Sole	2021-05-13
2020-12-31	$2,445,521	41,976	-1.2%	Shares	Sole	2021-02-09
2020-09-30	$2,684,374	42,481	+105.8%	Shares	Sole	2020-11-12
2020-06-30	$1,588,503	20,646	-33.7%	Shares	Sole	2020-08-11
2020-03-31	$2,327,129	31,128	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.